Last reviewed · How we verify

Treatment with oral sucrosomial iron — Competitive Intelligence Brief

Treatment with oral sucrosomial iron (Treatment with oral sucrosomial iron) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Iron supplement (oral formulation). Area: Hematology / Nutritional deficiency.

marketed Iron supplement (oral formulation) Iron (Fe3+) absorption pathway Hematology / Nutritional deficiency Small molecule Live · refreshed every 30 min

Target snapshot

Treatment with oral sucrosomial iron (Treatment with oral sucrosomial iron) — University of Rochester. Sucrosomial iron delivers iron in a lipid-based carrier that enhances intestinal absorption and bioavailability while reducing gastrointestinal irritation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Treatment with oral sucrosomial iron TARGET Treatment with oral sucrosomial iron University of Rochester marketed Iron supplement (oral formulation) Iron (Fe3+) absorption pathway

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Iron supplement (oral formulation) class)

  1. University of Rochester · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Treatment with oral sucrosomial iron — Competitive Intelligence Brief. https://druglandscape.com/ci/treatment-with-oral-sucrosomial-iron. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: